Atracurium Besylate Injection, Solution
Product Images NDC 55150-217

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Atracurium Besylate (NDC 55150-217). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Auromedics Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (100 mg per 10 mL (10 mg / mL) [multi-use val])

Label for Atracurium Besylate Injection, USP, 100 mg per 10 mL (10 mg/mL) solution for intravenous injection in a 10 mL sterile multiple-dose vial. The label includes a warning that it is a paralyzing agent and contains benzyl alcohol. It is manufactured by AuroMedics Pharma LLC and provides storage instructions to refrigerate at 2° to 8°C and to protect from light.*

FDA Label Image

Package Label-principal Display Panel (100 mg per 10 mL (10 mg / mL) [multi-use vials])

Atracurium Besylate Injection, USP 100 mg per 10 mL (10 mg/mL) sterile, non-pyrogenic intravenous injection solution. The label shows a 10 x 10 mL multiple-dose vial package distributed by AuroMedics Pharma LLC. It includes warnings of the product being a paralyzing agent and contains benzyl alcohol as a preservative. The label also provides storage instructions and cautions for use.*

FDA Label Image

Package Label-principal Display Panel (10 mg/mL)

Label of Atracurium Besylate Injection, USP, showing a strength of 10 mg/mL in solution form for intravenous use. The label includes instructions to peel off and apply to a syringe and spaces for date, time, and person administering the dose. Manufactured by AuroMedics Pharma LLC.*

FDA Label Image

Atracurium Besylate Chemical Structure (Atracurium Str)

Chemical structure of Atracurium Besylate, showing two quaternary ammonium groups, aromatic rings with methoxy substitutions, and a besylate counterion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.